![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
Learning 500 Chinese characters in 30 days is possible. |
| Neoplasms of the CNS |
|
Free Subscription
2 AJNR Am J Neuroradiol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Neoplasms of the CNS is free of charge.
The Utility of Cystathionine Assessment using proton MR Spectroscopy for the
Preoperative Differential Diagnosis of Adult-Type Diffuse Gliomas.
AJNR Am J Neuroradiol. 2026 Feb 6:ajnr.A9192. doi: 10.3174/ajnr.A9192.
PubMed
Abstract available
Clinical Validation of Deep Learning-Accelerated versus Wave-CAIPI Postcontrast
3D T1-MPRAGE for Evaluation of Intracranial Enhancing Lesions.
AJNR Am J Neuroradiol. 2026;47:394-400.
PubMed
Abstract available
Efficacy and influencing factors of bevacizumab monotherapy and combination
therapy in recurrent high-grade glioma: a twelve-year experience.
BMC Neurol. 2026 Feb 2. doi: 10.1186/s12883-026-04665.
PubMed
Multifocal spinal recurrence of intramedullary melanocytoma: a rare case report.
BMC Neurol. 2026;26:65.
PubMed
Abstract available
The safety of trastuzumab deruxtecan (T-DXd) in breast cancer brain metastases
with a focus on interstitial lung disease/pneumonitis: A systematic review and
meta-analysis.
Cancer. 2026;132:e70268.
PubMed
Abstract available
Enozertinib Is a Selective, Brain-Penetrant EGFR Inhibitor for Treating Non-Small
Cell Lung Cancers with EGFR Exon 20 and Atypical Mutations.
Cancer Res. 2026;86:759-772.
PubMed
Abstract available
Preoperative hydrocephalus and the risk of postoperative speech impairment
following posterior fossa tumour surgery in children: results from a prospective,
multinational cohort study.
Childs Nerv Syst. 2026;42:60.
PubMed
Abstract available
Nordic survey on practice of neurosurgical management of craniopharyngioma in
children.
Childs Nerv Syst. 2026;42:59.
PubMed
Abstract available
A genomically-tailored multi-agent precision medicine clinical trial for adults
with recurrent glioblastoma.
Clin Cancer Res. 2026 Feb 6. doi: 10.1158/1078-0432.CCR-25-4080.
PubMed
Abstract available
18F-DOPA-PET and advanced MRI improve treatment response assessment in
IDH1/2-mutant gliomas treated with IDH inhibitors.
Clin Cancer Res. 2026 Feb 2. doi: 10.1158/1078-0432.CCR-25-0279.
PubMed
Abstract available
Heat or Healing? Dealing With "Something That Looks Like Progression" of Brain
Metastases.
Int J Radiat Oncol Biol Phys. 2026;124:572.
PubMed
Too Hot to Handle? Navigating the Dilemma of Radiation Necrosis After
Stereotactic Radiosurgery for Brain Metastases.
Int J Radiat Oncol Biol Phys. 2026;124:570-571.
PubMed
A Mechanistic Model of Brain Necrosis Progression Based on Vascular
Heterogeneity.
Int J Radiat Oncol Biol Phys. 2026;124:842-855.
PubMed
Abstract available
Investigating the FLASH Effect in a Rat Brain Organotypic Model With a Novel
High-Energy Electron Beam.
Int J Radiat Oncol Biol Phys. 2026;124:759-764.
PubMed
Abstract available
FOXC1 expression and radiological predictors of peritumoral brain edema in
meningiomas.
J Neurooncol. 2026;176:194.
PubMed
Abstract available
Clinical characteristics and surgical outcomes of intradural spinal metastases: a
comparative analysis between intramedullary and extramedullary lesions.
J Neurooncol. 2026;176:193.
PubMed
Abstract available
Construction and application of an ERAS-based nursing pathway for postoperative
pain management in brain tumor patients.
J Neurooncol. 2026;176:192.
PubMed
Socioeconomic disparities in glioma outcomes: a grade-specific analysis.
J Neurooncol. 2026;176:195.
PubMed
Impact of Carmustine wafer implantation in epileptic seizures of newly diagnosed
glioblastomas, IDH-wildtype in adults.
J Neurooncol. 2026;176:196.
PubMed
Abstract available
Gliomas with succinate dehydrogenase deficiency: A case series and brief review
of the literature of oncometabolite-driven gliomagenesis.
J Neuropathol Exp Neurol. 2026 Feb 4:nlag004. doi: 10.1093.
PubMed
Abstract available
Toward data-driven surgical planning: multimodal mapping correlates of aphasic
surgical deficits.
J Neurosurg. 2025;144:324-335.
PubMed
Abstract available
Letter to the Editor. From Simpson grade to Ki-67 index for prognostic
stratification of meningioma.
J Neurosurg. 2026 Jan 30:1-2. doi: 10.3171/2025.8.JNS251996.
PubMed
Deciphering the tumor microenvironment and role of immunotherapy in Diffuse
Midline Glioma: a scoping review.
Neuro Oncol. 2026 Feb 2:noag014. doi: 10.1093.
PubMed
Abstract available
Meningioma microenvironment harbors a rich immune landscape that evolves with
biological state.
Neuro Oncol. 2026 Feb 2:noag022. doi: 10.1093.
PubMed
Abstract available
Beyond base camp: PI3K/mTOR inhibition for the treatment of pediatric high-grade
gliomas.
Neuro Oncol. 2025 Sep 11:noaf163. doi: 10.1093.
PubMed
Abstract available
lncRNA LUCAT1 Regulates DNA Damage Response in Glioma Stem Cells Under Hypoxia.
Neuro Oncol. 2026 Jan 31:noag017. doi: 10.1093.
PubMed
Abstract available
Distinct tumor immune microenvironmental (TIME) landscapes drive divergent
immunotherapy responses in glioblastoma.
Neuro Oncol. 2026 Jan 31:noag018. doi: 10.1093.
PubMed
Abstract available
Preclinical efficacy of combinatorial B7-H3 CAR T cells and ONC206 against
diffuse intrinsic pontine glioma.
Neuro Oncol. 2026 Feb 4:noag025. doi: 10.1093.
PubMed
Abstract available
Extracranial meningioma of the masticator space: a rare case report.
Neuroradiology. 2026 Feb 5. doi: 10.1007/s00234-026-03905.
PubMed
Validation of automated DTI-ALPS and free water index as potential survival
stratification markers in IDH-wildtype glioblastoma.
Neuroradiology. 2026 Feb 6. doi: 10.1007/s00234-026-03928.
PubMed
Abstract available
The Safety and Efficacy of Laser Interstitial Thermal Therapy for Newly Diagnosed
Deep-Seated Low-Grade Glioma: A Pilot Study Comparing Outcomes With a Surgical
Cohort.
Neurosurgery. 2026 Feb 5. doi: 10.1227/neu.0000000000003951.
PubMed
Abstract available
Boosting brain tumor segmentation: A novel 3D pooling approach with U-net 3D.
PLoS One. 2026;21:e0336514.
PubMed
Abstract available
Early onset radiation-induced leukoencephalopathy in patients treated for a
glioblastoma by STUPP protocol and risk factors evaluation, an ancillary study of
the phase III ASTER protocol.
Rev Neurol (Paris). 2026 Feb 4:S0035-3787(26)00024.
PubMed
Abstract available
Thank you for your interest in scientific medicine.